NASDAQ
Arrowhead Pharmaceuticals, Inc. (ARWR) has a price/fcf ratio of 29.41x as of Monday, May 25, 2026. This represents a 816.59% increase compared to its 12-month average of 3.21x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.